Navigation Links
Hospira Reports First-Quarter 2012 Results
Date:5/1/2012

s, net. These charges relate to facilities optimization from the closure or departure from certain manufacturing and research and development ("R&D") facilities and include costs for severance and other employee benefits, accelerated depreciation and relocation of production and R&D operations.(C)

Amortization and impairment of certain intangible assets: $19.4 million reported in Cost of products sold and $1.7 million reported in Restructuring, impairment and (gain) on disposition of assets, net resulting from acquisitions including Mayne Pharma, Javelin Pharma and a generic injectable business by Hospira India.(D)

Other restructuring charges: $7.8 million reported in Restructuring, impairment and (gain) on disposition of assets, net for distribution contract termination charges related to certain Latin America operations.(E)

Settlement of IRS tax audit benefit of $19.7 million reported in Income tax expense.  This discrete income tax benefit is related to the completion and effective settlement of U.S. tax return audits.(1)

Gross profit is defined as Net sales less Cost of products sold.(2)

Adjusted Net Income is shown net of tax of $19.3 million and $12.3 million exclusive of the 2011 tax audit settlement for the three months ended March 31, 2012 and 2011, respectively, based on the statutory tax rates in the various tax jurisdictions in which the items occurred.(3)

The Non-GAAP financial measures contained in this press release (including adjusted gross profit, adjusted income from operations, adjusted net income and adjusted diluted Earnings Per Share) adjust for certain specified items. All Non-GAAP financial measures are intended to supplement the applicable GAAP measures and should not be considered in isolation from, or a replacement for, financial measures prepared in accordance with GAAP. Refer to Hospira’s filing on Form 8-K filed on May 1, 2012 for additional information.Hospira, Inc.Conde
'/>"/>

SOURCE Hospira, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine technology :

1. Hospira to Present at the Bank of America Merrill Lynch 2012 Health Care Conference
2. Hospira Joins the Generic Pharmaceutical Association
3. Hospira Works With FDA to Help Avert Methotrexate Shortage; Shipping One Months Supply of New Product Immediately and on Track to Ensure Sustainable Supply
4. Hospira Announces Start of U.S. Phase III Biosimilar EPO Clinical Program
5. Hospira to Host Conference Call for Fourth-Quarter 2011 Results and 2012 Projections
6. Hospira to Present at the J.P. Morgan 30th Annual Healthcare Conference Jan. 10, 2012
7. Hospira Reports Third-Quarter 2011 Results
8. Hospira Announces Certain Preliminary Third-Quarter 2011 Results
9. Hospira to Host Conference Call for Third-Quarter 2011 Results
10. Hospira Announces Positive Results From Phase I U.S. Clinical Trial of Biosimilar Erythropoietin in Renal Patients
11. Hospira to Host 2011 Investor Day
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)...   Royal Philips (NYSE: ... received 510(k) clearance from the U.S. Food and ... for Transcatheter Aortic-Valve Implantation (TAVI) treatments. Through 3D ... pre-procedural, high-precision positioning to treat aortic stenosis ailments.  ... available as part of Philips IntelliSpace Portal ...
(Date:8/20/2014)... 2014 Northstar Global Business Services, Inc., ... of hard work from many talented specialists, the ... and package design.  The new formulation for Snorenz ... the product due to overwhelming evidence of increased ... Nighttime will also include these vitamins, as well ...
(Date:8/20/2014)... 20, 2014  The National Association of Drug ... achieved by the real-time, pseudoephedrine (PSE) blocking system ... Log Exchange (NPLEx), automatically blocks unlawful pseudoephedrine sales ... offenders and make arrests. Data released by NPLEx ... blocked the sale of more than 32,890 ...
Breaking Medicine Technology:Philips receives FDA 510(k) Clearance for TAVI Precision Treatment Planning Application 2Philips receives FDA 510(k) Clearance for TAVI Precision Treatment Planning Application 3Northstar completes the first phase of its new retail strategy and prepares to ship reformulated Snorenz with all new packaging 2Michigan's Stop-Sale System Achieves Significant Results In Battle Against Meth 2
... Industries, Inc., a manufacturer of OTC drug products has ... Chief Operating Officer,s (COO) role.   Vize ... and Biotechnology field to H&P mostly with Abbott Laboratories. ... Validations to H&P as they begin to restart their ...
... 2011 Eurotech , a leading supplier of ... been selected to supply embedded computers to ... diagnostics solutions.  The value of the six-month contract is ... The Eurotech Sphere II will allow the customer to ...
Cached Medicine Technology:Eurotech Awarded 1.5M USD Contract to Supply Embedded Computers for Medical Application 2
(Date:8/21/2014)... not protest being overcompensated, even when there are ... and Behavior Program have found. , This could ... believed about the inequity of others, researchers said. ... Brain Connectivity . These findings suggest humans, sense ... the interest humans show in others, outcomes is ...
(Date:8/21/2014)... Home Care Assistance of Centennial ... that it has received the Certified – Trusted Provider ... Care Assistance’s commitment to client satisfaction. , “Our goal ... client’s in the South Metro Denver area are receiving ... of Home Care Assistance of Centennial. “Home Care ...
(Date:8/21/2014)... and health authorities need to ensure that experimental drugs ... context of randomized controlled trials, according to a new ... 21 August, 2014]. , Leading bioethicists Professor ... and Dr Annette Rid, of King,s College London, UK, ... to if experimental drugs are to be deployed in ...
(Date:8/21/2014)... CA (PRWEB) August 21, 2014 ... of American Corporate Health, was recently recognized ... influential professionals in the field of workers’ ... National Workers’ Compensation and Occupational Medicine Conference ... including attorneys, physicians, nurses, case managers, disability ...
(Date:8/21/2014)... (PRWEB) August 21, 2014 According to ... "Medical Fiber Optics Market-Global Industry Analysis, Size, Share, Growth, ... fiber optics market was valued at USD 863.1 million ... CAGR of 7.6% from 2013 to 2019, to reach ... , The medical fiber optics market is witnessing significant ...
Breaking Medicine News(10 mins):Health News:Influenced by self-interest, humans less concerned about inequity to others 2Health News:Influenced by self-interest, humans less concerned about inequity to others 3Health News:Home Care Assistance of Centennial Receives Home Care Pulse Certified – Trusted Provider Distinction 2Health News:Home Care Assistance of Centennial Receives Home Care Pulse Certified – Trusted Provider Distinction 3Health News:The Lancet: Experimental Ebola drugs must be fairly distributed and tested ethically in clinical trials 2Health News:Dr. Vasili Gatsinaris Named One of the Top 50 Most Influential in Workers’ Compensation 2Health News:Global Medical Fiber Optics Market: Industry Analysis, Size, Share, Growth, Trend and Forecast 2013 - 2019 2Health News:Global Medical Fiber Optics Market: Industry Analysis, Size, Share, Growth, Trend and Forecast 2013 - 2019 3Health News:Global Medical Fiber Optics Market: Industry Analysis, Size, Share, Growth, Trend and Forecast 2013 - 2019 4
... recurrence of breast cancer shows promise in fighting life-threatening ... born prematurely and patients with cancer. Some scientists suspected ... the University of Rochester Medical Center shows that it ... disease. "It,s still early, but if tamoxifen, or ...
... ... to share their experiences and tips on keeping kids healthy and active this summer ... Minneapolis, MN (PRWEB) July 20, ... and television aside as they enjoy the summer sun. While the occasional bump or bruise ...
... , , Stronger ... WASHINGTON, July 20 Five organizations representing the nation,s ... public health and disease prevention announced their support for a provision ... within the healthcare reform bill introduced by leaders of the U.S. ...
... July 20 The following was released today by Randall Terry, founder of Operation ... discussing potential backlash -- including the potential of unwanted violence -- if Congress votes ... Address: National Press Building, 529 14th Street NW, Washington, DC , ... , Leaders to be present: , , ...
... , , ... Competition between employer-based health insurance plans and a government-sponsored public ... the majority of employers responding to a Health Care Reform Survey, ... Aon Corporation (NYSE: AOC ). What will help ...
... , , , ... CareFusion Corporation, the company that will become publicly traded following ... of Cardinal Health, today announced it has expanded its Pyxis((R)) ... (ORIS), incorporate radio-frequency identification (RFID) technology(1) and include new services. ...
Cached Medicine News:Health News:Breast cancer drug shows promise against serious infections 2Health News:Treating Kids' Summertime Bumps, Bruises and Injuries with The Healthcare Scoop 2Health News:Treating Kids' Summertime Bumps, Bruises and Injuries with The Healthcare Scoop 3Health News:Experts Support National Public Reporting of Healthcare-Associated Infections 2Health News:Experts Support National Public Reporting of Healthcare-Associated Infections 3Health News:Employers Express Doubts About Employer Mandate and Government-Sponsored Public Plan, Says Aon Consulting Survey 2Health News:Employers Express Doubts About Employer Mandate and Government-Sponsored Public Plan, Says Aon Consulting Survey 3Health News:Employers Express Doubts About Employer Mandate and Government-Sponsored Public Plan, Says Aon Consulting Survey 4Health News:Employers Express Doubts About Employer Mandate and Government-Sponsored Public Plan, Says Aon Consulting Survey 5Health News:CareFusion Expands Pyxis(R) Perioperative Solutions Offering 2Health News:CareFusion Expands Pyxis(R) Perioperative Solutions Offering 3Health News:CareFusion Expands Pyxis(R) Perioperative Solutions Offering 4Health News:CareFusion Expands Pyxis(R) Perioperative Solutions Offering 5
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: